Powered by

Creative Medical Technology Holdings Appoints Internationally Renowned Stem Cell Pioneer as Chief Scientific Officer

Mar 08, 2017 - PR Newswire
Board and Executive Moves

 Creative Medical Technology Holdings, Inc.(OTCQB: CELZ) announced today the appointment of Dr. Thomas Ichim to the position of Chief Scientific Officer.  Dr. Ichim will lead development of the Company's clinical stage CaverStemTM personalized stem cell therapy for erectile dysfunction, as well as advance preclinical and eventually clinical studies on the Company's universal donor AmnioStemTM stem cell therapy for post-stroke recovery.

"It is my honor to welcome Dr. Ichim to the position...